Prophylaxis (Cytomegalovirus)
Better Dosing is Required for Valaciclovir
Published in Blood Weekly, March 16th, 1998
More work is needed, however, to find a dose of valaciclovir that patients can better tolerate, reported Judith E. Feinberg, University of Cincinnati, Cincinnati, Ohio, and colleagues ("A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection," the Journal of Infectious Diseases, 1998;177:48-56).
Cytomegalovirus (CMV) end-organ disease, especially retinitis, commonly occurs as a serious complication of advanced HIV infection.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1998-03-16)
More Articles from Blood Weekly
- Conference Coverage (Blood Safety)
GAT Reduces Window Period for HIV and HCV; not HBV - Conference Coverage (Blood Safety)
No Reported Toxicity Problems with Solvent/Detergent Plasma - Conference Coverage (Blood Safety)
Simple Iodine Treatment Applicable to Plasma Products - Conference Coverage (Blood Safety)
UVC Is Suitable As Supplemental Viral Kill Treatment - Disease Associations
United Kingdom To Import Blood Plasma as "Mad Cow" Move - Drug Development
U.S. FDA Approves Hydroxyurea To Treat Sickle-Cell Anemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
